LCII
LCI Industries
LCII offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
NKE
NIKE, Inc.
NKE has the edge over LCII overall, supported by stronger valuation and stronger modeled upside.
LCII Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Stable | |
| Healthy |
LCII's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is under pressure.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
LCII PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $78.22 | -19% |
| Current | 12x | $96.99 | — |
| Fair | 16x | $132 | +36% |
| Expensive | 26x | $212 | +119% |
Historical ranges are pointers, not guarantees.
LCII's PE is in its cheap range at 12x.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over LCII in the historical PE scenario, which offers more potential upside but is not a forecast.
LCII Forward outlook
There aren't enough analyst estimates for LCII to show an outlook.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
LCII Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $8.12 | +14% |
| Q2 2026 | $8.62 | +44% |
| Q1 2026 | $8.16 | +34% |
| Q4 2025 | $7.57 | +35% |
| Q3 2025 | $7.15 | +39% |
| Q2 2025 | $5.99 | +26% |
| Q1 2025 | $6.10 | +66% |
| Q4 2024 | $5.60 | +122% |
LCII has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
LCII Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $992.5M | -4.2% |
| Q2 2026 | $968.7M | -13% |
| Q1 2026 | $1.1B | +4.3% |
| Q4 2025 | $932.7M | +16% |
| Q3 2025 | $1B | +13% |
| Q2 2025 | $1.1B | +5% |
| Q1 2025 | $1B | +8% |
| Q4 2024 | $803.1M | -4.1% |
LCII has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.6% | +0.3 points |
| Q2 2026 | 9.9% | +2 points |
| Q1 2026 | 8.7% | +1 points |
| Q4 2025 | 3.8% | +1.8 points |
| Q3 2025 | 7.3% | +1.4 points |
| Q2 2025 | 7.9% | -0.7 points |
| Q1 2025 | 7.8% | +1.8 points |
| Q4 2024 | 2% | +1.7 points |
LCII's operating margin was 7.6% last quarter, about level with the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE has the edge over LCII on profitability, with a higher operating margin.
LCII Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $53.6M | -34% |
| Q2 2026 | $184.9M | +86% |
| Q1 2026 | -$43.1M | -228% |
| Q4 2025 | $64.3M | -33% |
| Q3 2025 | $80.9M | +18% |
| Q2 2025 | $99.5M | -45% |
| Q1 2025 | $33.7M | +$49.9M |
| Q4 2024 | $95.7M | -24% |
LCII has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
LCII Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +25K shares |
| 1 year | -0.2% | -49K shares |
| 3 years | -4.3% | -1.1M shares |
| 5 years | -3.9% | -1M shares |
| Available history | -2.7% | -676K shares |
LCII has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $62.2M |
| Q2 2025 | $38.1M |
| Q1 2025 | $28.3M |
LCII hasn't bought back shares in the past year.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
LCII Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 2.0x | Healthy |
| Q2 2025 | 2.1x | Moderate |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 1.7x | Healthy |
LCII's net debt is about 1.4 years of its operating earnings (EBITDA), down from 2.0 years a year ago.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over LCII on leverage, with a lower net debt burden relative to earnings.
LCII Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.6 | Neutral |
| Stochastic | 63.9 | Neutral |
LCII's weekly RSI is 49 (neutral) and its Stochastic is 64 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
LCII PE vs Consumer Cyclical Sector
| Metric | LCII | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 18x | 34% below |
| PE % | 23 | 47 | 24 pts below |
LCII has the edge over NKE on valuation relative to its sector.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
LCII Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $88.5 | 9.6% above |
| 20 week MA | $96.3 | 0.7% above |
| 50 week MA | $112.3 | 14% below |
| 100 week MA | $104.4 | 7.1% below |
| 200 week MA | $109.8 | 12% below |
LCII has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
LCII Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $108.7 | $134.3 | +24% |
| 2021 | $134.3 | $149.9 | +12% |
| 2022 | $149.9 | $94.8 | -37% |
| 2023 | $94.8 | $125.7 | +33% |
| 2024 | $125.7 | $102.7 | -18% |
| 2025 | $102.7 | $123.7 | +20% |
| 2026 YTD | $123.7 | $97.0 | -22% |
LCII has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.